Abiopharma

🔍 Van't Hof Matthew Kaes (Director)

Company: Diamondback Energy, Inc. (FANG)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Sold 5,000 shares of Common Stock at $202.4632 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 125,940.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $202.325 per share to $202.625 per share, inclusive. The reporting person undertakes to provide to Diamondback Energy, Inc., any security holder of Diamondback Energy, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.